|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: DURA PHARMACEUTICALS INC, 10-K405/A, EX-23, 2000-08-01 |
Next: DURA PHARMACEUTICALS INC, S-4/A, 2000-08-01 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED BALANCE SHEET AS OF DECEMBER 31, 1999, AND THE RELATED
CONSOLIDATED STATEMENT OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 1999 AND
THE NOTES THERETO, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
CONSOLIDATED FINANCIAL STATEMENTS AND NOTES.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-END> DEC-31-1999
<CASH> 63,631
<SECURITIES> 210,782
<RECEIVABLES> 48,218
<ALLOWANCES> 3,586
<INVENTORY> 12,938
<CURRENT-ASSETS> 343,506
<PP&E> 113,509
<DEPRECIATION> (20,176)
<TOTAL-ASSETS> 883,474
<CURRENT-LIABILITIES> 87,581
<BONDS> 287,500
0
0
<COMMON> 44
<OTHER-SE> 441,695
<TOTAL-LIABILITY-AND-EQUITY> 883,474
<SALES> 231,776
<TOTAL-REVENUES> 301,426
<CGS> 45,839
<TOTAL-COSTS> 252,369
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 18,175
<INCOME-PRETAX> 44,448
<INCOME-TAX> 14,444
<INCOME-CONTINUING> 30,004
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 30,004
<EPS-BASIC> 0.68
<EPS-DILUTED> 0.66
</TABLE>
|
|